Anti-GAD antibodies - lndicatious in clinical practice

Authors

  • Mª Cristina Esteves Assistente Hospitalar de Medicina Interna, Serviço de Medicina IV do Hospital de Santa Maria, Lisboa
  • Rui Duarte Assistente Hospitalar de Diabetologia, Serviço de Medicina IV do Hospital de Santa Maria, Lisboa
  • Jorge L. Caldeira Assistente Hospitalar Graduado de Diabetologia, Serviço de Medicina IV do Hospital de Santa Maria, Lisboa

Keywords:

antibodies anti-GAD, type 1 diabe­tes, autoimmunity

Abstract

The pathogenesis of type 1 diabetes ( characte­ rized by insulin deficiency) is caused by an auto immune process against the pancreatic islet f3 cells. lt occurs when a genetic susceptibility in­ teracts with multiple environmental agents. The evidence for an auto-immune basis comes from the recognition of insulitis and the presence of multiple auto-antibodies to {3-cell constituents. ln the early pre-clinical phase of type l diabetes, antibodies to islet cell antigens are detected, in­ cluding: lCA (islet cell antibodies), lAA (insulin auto-antibodies) and anti-GAD (glutamic acid decarboxylase antibodies). The anti-GAD antibody is the main auto-immune marker. When detected in the pre-clinical phase of disease, it allows us to predict future insulin dependency. lts contri­bution to the classification oftype l diabetes in the young non-obese adult and in gestacional diabetes is discussed. ln the future the utilisati­on of anti-GAD could be useful in primary pre­ vention with antigen immunotherapy.

Downloads

Download data is not yet available.

References

Atkinson MA, Maclaren NK. The pathogenesis of insulin-de­pendent diabetes mellitus. N Engl J Med 1994; 331: 1428-

Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell anti­ bodies in diabetes mellitus with autoimmune plyendocrine deficiencies. Lancet 1974; ii: 1279-1283.

Baekkeskov S, Landin M, Kristensen JK et al. Antibodiesto a 64000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes.J Clin Invest 1987; 79: 926-934.

Atkinson MA, Maclaren NK, Sharp DW et al. 64000Mr autoanti­bodies as predictors of insulin-dependent diabetes. Lancet 1990; 335: 1357-1360.

Baekkeskov S, Aanstoot HJ, Christgau S et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA- synthesizing enzyme glutamic acid decarhoxylase. Nature 1990; 347: 151-156.

Erlander MG, Tillakaratne NJ, Feldhlum S et al. Two genes en­code distinct glutamate decarboxylases. Neuron 1991; 7: 91-100.

Bu DF, Erlander MG, Tillakaratne NJ, te al. Two glutamate decar­boxylases, 65 kDa GAD and 67 kDa GADare each encoded by a single gene. Proc Natl Acad Sci USA 1992; 89: 2115- 2119.

Hagopian WA, Michelsen B, Karlsen AE et ai. Autoantibodies in IDDM primarily recognize the 65000Mr rather than the 67000Mr isoform of glutamic acid decarboxylase. Diabetes 1993; 42: 631-636.

Solimena M, Folli F, Denis-Donini S et al. Autoantibodies to glu­tamic acid decarboxylase in a patient with stiff-man syndro­me, epilepsy, and Type 1 diabetes mellitus. N Engl J Med 1988; 318: 1012-1020

O. Solimena M, Folli F, Aparisi R et al. Autoantihodies to GABA­ ergic neurons and pancreatic heta cells in stiff-man syndro me. N Engl J Med 1990; 322: 1555-1560.

Szopa TM, Titchener PA, Partwood ND et al. Diabetes mellitus due to viruses- some recent developments. Diabetologia 1993; 36: 687-695.

Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, Ma­daren NK, Tohin AJ. Autoimmunity to two forms of gluta­mate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992; 89: 283-292.

Serjeant,on SW, Kohonen-Corish MR, Rowley MJ et al. Antibo­dies to glutamic acid decarboxylase are associated with HLA­ DR genotypes in both Australians and Asians with Type 1 diabetes mellitus. Diabetologia 1992; 35: 996-1001.

National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intoleran­ce. Diabetes 1979; 28: 1039-1057.

Molhac AC, Christau B, Marner B et al. lncidence of insulin­ dependent diabetes mellitus in age groups over 30 years in Denmark-Diahetic Med 1994; 11: 650-655.

Groop LC, Bottazzo GF, Doniach D. Islet cell antihodies iden­tify latent type 1 diabetes in patients aged 35-75 years at diagnosis. Diabetes 1986; 35: 237-241.

Tuomi T, Groop LC, Zimmet PZ et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes me­llitus in adults with a non-insulin-dependent onset of disea­se. Diabetes 1993; 42: 359-362.

Zimmet P, MD, PHD . The pathogenesis and prevention of diabetes in adults. Diabetes Care 1995; 18; (7): 1050-1064.

Zimmet P: Type 2 (non-insulin-dependent) diahetes- an epi­demiological overview. Diabetologia 1982; 22: 399-411.

Dussoix P, Vaxillaire M, Patrick B et ai. Diagnostic heteroge­ neity of diabetes in Jean young adults- dassification based on immunological and genetic parameters. Diabetes 1997; 46: 622-631.

Zimmet PZ, Tuomi T, Mackay IR et al. Latent autoimmune dia­betes mellitus in adults ( LADA ): the role of antihodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. DiabeticMed 1994; 11: 299-303.

Thivolet CH, Tappaz M, Durand A et al. Glutamic acid decar­ boxylase autoantihodies are additional predictive markers of Type 1 diabetes mellitus in hight risk individuals. Diabetologia 1992; 35: 570-576.

Zimmet PZ, Elliot RB, Mackay IR et al. Autoantibodies to gluta­ mic acid decarhoxylase and insulin in islet cell antihody positive presymptomatic Type 1 diahetes mellitus: frequen­cy and segregation by age andgender. Diabetic Med 1994; 11: 866-871.

Palmer JP. What is the best way to predict IDDM. Lancet 1994; 343, 8910: 1377-1378.

Rowley MJ, Mackay IR, Chen QY et al. Antibodies to glutamic acid decarhoxylase discriminate major types of diabetes mellitus. Diabetes 1992; 41: 548-551

Batstra M, Pina M, QuanJ et al. Flutuations in GAD 65 antiho­ dies after clinical diagnosis of IDDM in young children. Di­abetes Care 1997; 20 (4): 642-644.

Chen QY, Rowley MJ, Byrne GC et al. Antihodies to glutamic acid decarhoxylase in Australian children with insulin-de­pendent diabetes mellitus and their first degree relatives. Pediatr Res 1993; 34: 785-790.

Petersen J, Dyrherg T, Damm P et al. GAD65 autoantibodies in woman with gestational or insulindependent diabetes me­llitus diagnosed during pregnancy. Diabetologia 1996; 39: 1329-1333.

Tuomilehto J, Zimmet P, MacKay IR et al. Antihodies to gluta­mic acid decarboxylase as predictors of insulindependent diabetes mellitus before clinical onset of disease. Lancet 1994; 343: 1383-1385.

Keller RJ, Eisenbarth GS, Jackson RA. lnsulin prophylaxis in individuais at risk of type 1 diabetes. Lancet 1993; 341: 927-

Additional Files

Published

1998-06-30

How to Cite

1.
Esteves MC, Duarte R, Caldeira JL. Anti-GAD antibodies - lndicatious in clinical practice. RPMI [Internet]. 1998 Jun. 30 [cited 2025 Apr. 1];5(2):117-21. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/2132

Issue

Section

Review Articles

Most read articles by the same author(s)